← Back to Search

ARCR augmented with REGENETEN™ Bioinductive Implant for Rotator Cuff Injury (REGENETEN Trial)

N/A
Waitlist Available
Led By Chris Peach, MBBS MD FRCS (Tr&Orth)
Research Sponsored by Smith & Nephew, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 6 weeks, 3, 6, 12 and 24 months
Awards & highlights

Summary

This trial is testing whether a new medical device called REGENETEN can help people who need surgery to repair a torn rotator cuff.

Eligible Conditions
  • Rotator Cuff Injury
  • Rotator Cuff Tears

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 6 weeks, 3, 6, 12 and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 6 weeks, 3, 6, 12 and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6 months retear rate
Secondary outcome measures
Constant-Murley Score
Cumulative duration of opioid use in ARCR augmented with REGENETEN versus ARCR alone
EuroQol 5 Dimension 5 Level (EQ-5D-5L) Score
+14 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: ARCR revision groupExperimental Treatment1 Intervention
ARCR revision group allows treatment of subjects having recurrent tears, ARCR supplemented with REGENETEN
Group II: ARCR augmented with REGENETEN™ Bioinductive ImplantExperimental Treatment1 Intervention
During the ARCR procedure, the REGENETEN™ Bioinductive Implant is covering the tendon and attached to the bone and the tendon with small anchors.
Group III: ARCR alonePlacebo Group1 Intervention
The rotator cuff is repaired during arthroscopic standard procedure. No product is added for healing

Find a Location

Who is running the clinical trial?

Smith & Nephew, Inc.Lead Sponsor
165 Previous Clinical Trials
22,348 Total Patients Enrolled
Chris Peach, MBBS MD FRCS (Tr&Orth)Principal InvestigatorManchester University NHS Foundation Trust
~26 spots leftby Jul 2025